Emma Costante, Vancouver

About Emma

Emma's practice covers a broad range of sectors and industries, including life sciences, health care, SaaS, AI and quantum computing, clean tech, and natural resources. A large part of Emma’s practice focuses on supporting innovative growth companies and particularly in the life science industry. She helps create negotiated solutions among stakeholders, including founder exits, government contracts and complex shareholder agreements.

Select Experience

Mergers, Acquisitions and Financings

Access Planning in connection with its acquisition by Nelson\Nygaard
DCx Biotherapeutics in its licensing and acquisition of certain assets from Repare Therapeutics
Convergint in connection with its purchase of the security division of Delco Automation Inc. for C$55-million
Eupraxia in connection with its C$44.5-million non-brokered private placement of preferred shares
Alpha-9 Oncology in connection with its US$175-million Series C preferred share financing
Orpyx Medical in connection with its US$20-million financing by Perceptive Advisors
Mediphage in connection with its seed round financing
Convergint in connection with its acquisition of Panavidéo
Disruption Ventures in connection with the C$1.5-million seed financing of Ginger Desk
HTEC in connection with its raise of C$337-million from the Canada Infrastructure Bank
Mediphage Bioceuticals in connection with its seed round financing
Conuma in connection with its purchase of the Quintette coal mine assets from Teck Resources for C$120-million
enGene in connection with its public transaction through a merger with a SPAC, Forbion European Acquisition Corporation, in a deal with US$138-million in gross proceeds
Abdera in connection with its US$110-million Series B financing
Tasktop Technologies Incorporated on its C$100-million in new financing from Sumeru Equity Partners
Alpha-9 Theranostics in connection with its US$75-million Series B financing
Incisive Genetics in connection with its C$12-million seed financing
Notch Therapeutics in connection with its US$85-million Series A financing
Later.com on its acquisition by Mavrck, in a deal funded by Summit Partners
adMare BioInnovations in connection with the C$8-million seed financing of Abdera Therapeutics
Hutton Family Holdings Ltd. in its acquisition of the assets of Fairview Cellars Winery
Alpha-9 Theranostics in connection with its US$11-million Series A financing
AbCellera Biologics in connection with its US$555.5-million initial public offering of common shares on NASDAQ
Brewster Travel Canada Inc. (an affiliate of Viad Corp.) on its acquisition of a majority equity interest in Mountain Park Lodges
D-Wave Systems Inc. in its public transaction through a merger with a SPAC, DPCM Capital, Inc., in a deal with an implied value of US$1.2-billion
Beijing BDStar Navigation Co., Ltd. on its acquisition of Canadian mobile positioning technology company Rx Networks Inc. with a total deal value of approximately C$31-million
Trilogy International Partners on its US$875-million business combination with Allignvest Acquisition Corporation, a special purpose acquisition corporation (SPAC)
Cognizant on their acquisition of Idea Couture, a privately held firm that offers digital innovation, strategy, design and technology services
Dominion Lending Centres Group in the sale of a 60% interest to Founders Advantage Capital Corp. for C$78-million
Foley's Candies in its sale to Yellow Point Equity Partners
Concert Infrastructure, Bird Construction and Bird Capital in their successful bid to construct, finance and maintain nine public-private partnership schools in Saskatchewan

Corporate Governance and Complex Commercial Transactions

Centre for Drug Research and Development in connection with its business combination with NEOMED Institute to create adMare BioInnovations
Acting for joint venture partners in forming various forms of joint ventures in the natural resource and manufacturing sectors

Representing companies and shareholders in complex governance matters, including the negotiation and renegotiation of complex multi-party shareholder agreements
Negotiating and drafting all manner of commercial and operational contracts specific to the retail, technology, agricultural and natural resource sectors

Competition and Foreign Investment

GlaxoSmithKline in connection with the Canadian antitrust aspects of its consumer healthcare, vaccines and oncology transactions with Novartis AG
Marine Harvest ASA on its acquisition of a significant minority interest in Grieg Seafood ASA